Wim Terryn
Overview
Explore the profile of Wim Terryn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Segers S, Sofie S, Jodie L, Langbeen J, Blot S, Stijn B, et al.
J Vasc Access
. 2024 Dec;
:11297298241305731.
PMID: 39663683
Introduction: Peripherally inserted central catheters (PICC) are the preferred vascular access for Outpatient Parenteral Antimicrobial Therapy (OPAT) due to user-friendliness and high safety level. Nevertheless, the lack of a validated...
2.
Jonckheere S, Mairesse C, Vandecandelaere P, Vanbiervliet J, Terryn W, Somers J, et al.
Pathogens
. 2024 Oct;
13(10).
PMID: 39452710
Prosthetic joint infections caused by are uncommon, with the majority of cases being attributed to . This case report represents the third instance of a prosthetic hip infection caused by...
3.
Osaer M, Terryn W, De Baere E, De Vriendt C, Haerynck F, Kerre T, et al.
Retin Cases Brief Rep
. 2024 Jul;
PMID: 39029109
Purpose: To report on a rare case of intermediate uveitis occurring in a patient with common variable immunodeficiency (CVID) and a heterozygous TNFRSF13B variant. Methods: Observational case report. Results: A...
4.
Schuermans N, El Chehadeh S, Hemelsoet D, Gautheron J, Vantyghem M, Nouioua S, et al.
Nat Genet
. 2023 Nov;
55(11):1929-1940.
PMID: 37919452
Phospholipase A/acyltransferase 3 (PLAAT3) is a phospholipid-modifying enzyme predominantly expressed in neural and white adipose tissue (WAT). It is a potential drug target for metabolic syndrome, as Plaat3 deficiency in...
5.
De Leeuw E, Van Damme K, Declercq J, Bosteels C, Maes B, Tavernier S, et al.
Respir Res
. 2022 Aug;
23(1):202.
PMID: 35945604
Background: The efficacy and safety of complement inhibition in COVID-19 patients is unclear. Methods: A multicenter randomized controlled, open-label trial. Hospitalized COVID-19 patients with signs of systemic inflammation and hypoxemia...
6.
Germain D, Altarescu G, Barriales-Villa R, Mignani R, Pawlaczyk K, Pieruzzi F, et al.
Mol Genet Metab
. 2022 Aug;
137(1-2):49-61.
PMID: 35926321
Fabry disease is an X-linked inherited lysosomal disorder that causes accumulation of glycosphingolipids in body fluids and tissues, leading to progressive organ damage and reduced life expectancy. It can affect...
7.
Schuermans N, Hemelsoet D, Terryn W, Steyaert S, Van Coster R, Coucke P, et al.
Orphanet J Rare Dis
. 2022 May;
17(1):210.
PMID: 35606766
Background: In order to facilitate the diagnostic process for adult patients suffering from a rare disease, the Undiagnosed Disease Program (UD-PrOZA) was founded in 2015 at the Ghent University Hospital...
8.
Hemelsoet D, De Keyser J, Van Heuverswyn F, Willems R, Vandekerckhove H, Bondue A, et al.
Circulation
. 2021 Feb;
143(8):872-874.
PMID: 33617311
No abstract available.
9.
De Mulder P, Cokelaere K, Terryn W
BMJ Case Rep
. 2020 Jan;
13(1).
PMID: 31980473
Dialysis-related amyloidosis (DRA) or β2microglobulin (β2m)-amyloidosis is a disorder caused by the inability to clear a protein called β2m in patients with chronic kidney disease. It results in deposition of...
10.
Steyaert W, Callens S, Coucke P, Dermaut B, Hemelsoet D, Terryn W, et al.
Acta Clin Belg
. 2018 Feb;
73(1):7-10.
PMID: 29384039
Introduction: In recent decades, we witnessed a revolution in genetic technology. Some 20 years ago, analysing a single gene was quite laborious and time-consuming. In addition, diagnostic testing was only...